A recent study of kinome profiling of breast cancer cell lines using unbiased multiplexed inhibitor beads (MIBs), mass spectrometry (MS) demonstrated that resistance to drugs that target PI3K components, including AKT and mTOR, was associated with a failure to inhibit AURKA. Here, MTOR is linked to breast carcinoma.